Sigyn Therapeutics Inc (SIGY): way undervalued at these levels, won't t...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: None

Monday, 01/09/2017 12:01:42 PM

Monday, January 09, 2017 12:01:42 PM

way undervalued at these levels, won't take much volume to bounce

RGNP

Keep Last Read

Replies (1) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 09:20:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:23:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 08:25:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 07:34:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 07:48:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 07:23:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 09:10:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2023 07:56:11 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:35:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 03:15:11 PM
Sigyn Therapeutics Discloses "DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES" Patent Submission and Related ImmunePrep™ Trademark Application • InvestorsHub NewsWire • 05/17/2023 11:15:02 AM

InvestorsHub NewsWire

Only $200 per official company press release!